Archive for the ‘publisher error’ Category
The Journal of Multivariate Analysis has retracted a paper it was never meant to publish — a problem, it seems, of multivariate analyses.
The article, titled “Regression estimation with locally stationary long-memory errors,” came from a pair of statisticians in Chile, Wildredo Palma and Guillermo Ferreira.
The paper in question was a June 2012 review by a group of researchers at the University of California, San Francisco’s division of pediatric surgery, titled “Maternal-Fetal Surgery: History and General Considerations.”
We’ve seen this movie before: Researchers present a study at a scientific meeting, then learn to their surprise (and, sometimes, chagrin) that a journal has published the data in a supplement or other edition.
The work was titled “Molecular mechanisms involved in resistance of CLL cells towards ABT-737, a specific BCL-2 inhibitor.” Gerald Cohen, of the University of Leicester, who led the study, told us: Read the rest of this entry »
Eighteen years ago, the Journal of Dermatology published an article, “A sulfated proteoglycan as a novel ligand for CD44,” by a group of Japanese researchers (the journal is the official periodical of the Japanese Dermatological Society).
The JoD is now retracting that paper because it overlaps with another article by the same group, published a few months earlier in a different journal.
Seyed Rasoul Mousavi, assistant professor in the department of electrical and computer engineering at the Isfahan University of Technology in Khomeynīshahr, Iran, has been working on a way to help biologists assemble genomes with as little information as possible.
Last year, Mousavi submitted a manuscript to the Journal of Theoretical Biology, received acceptance after peer review, and got proofs back to edit.
For technical reasons, Mousavi says his corrections didn’t make it into the final article published on Jan. 12, so the publishers issued a separate corrigendum with the editorial changes. Then, on Feb. 8, the publishers retracted the corrigendum that accompanied the original article. The retraction of the corrigendum reads: Read the rest of this entry »
Amarin pulls a Romney: For the second time in a week, premature news of FDA drug approval posted, then retracted
On Monday, USA Today inadvertently posted a story about the approval of Qsymia, a weight loss drug, several hours before the FDA made an announcement. Today, Amarin, which makes a compound designed to lower triglycerides, put up a site saying that the drug had been approved by the FDA. Trouble was, that decision isn’t expected until July 26. According to Reuters: Read the rest of this entry »
The FDA is scheduled to announce its decision on the subject of the story — Vivus’ Qnexa — today. The decision has been closely watched.
The story, headlined “New diet drug helps heavy patients lose 10% of weight,” includes a lot of reporting, including comments from the president of Vivus about a change in name from Qnexa to something else. (We’ll leave USA Today that apparent scoop, although others might not.) It was posted on the Salem, Oregon’s Statesman Journal at 12:16 p.m. today, presumably Eastern, since it was taken down before the West Coast arrived at 2 p.m. Read the rest of this entry »